Evidence map›Paper›PMID 38855719›Full record

ArticleCase reports in women's health2024

Severe fetal hemolytic disease due to anti-M alloimmunization: A case report and literature review.

Fatemeh Golshahi, Fatemeh Rahimi Sharbaf, Mahboobeh Shirazi, Behrokh Sahebdel, Jafar Golshahi, Simon Dadoun, Soroush Aalipour, Mohammad Haddadi

Abstract readCase Reports
In one paragraph

Article in Case reports in women's health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fatemeh GolshahiMaternal, Fetal, and Neonatal Research Center, Yas Hospital, Tehran University of Medical Science, Tehran, Iran.
Fatemeh Rahimi SharbafMaternal, Fetal, and Neonatal Research Center, Yas Hospital, Tehran University of Medical Science, Tehran, Iran.
Mahboobeh ShiraziMaternal, Fetal, and Neonatal Research Center, Yas Hospital, Tehran University of Medical Science, Tehran, Iran.
Behrokh SahebdelMaternal, Fetal, and Neonatal Research Center, Yas Hospital, Tehran University of Medical Science, Tehran, Iran.
Jafar GolshahiHypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Science, Isfahan, Iran.
Simon DadounBaylor College of Medicine, Houston, TX, USA.
Soroush AalipourBaylor College of Medicine, Houston, TX, USA.
Mohammad HaddadiVali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fetal hemolysis is caused by maternal antibodies that cross the placenta. Anti-M antibodies can rarely cause severe forms of alloimmunization in the fetus and newborn. We present a case of severe anti-M alloimmunization requiring a total of 8 intrauterine transfusions, in a patient with a prior poor obstetrical history. A 35-year-old Iranian pregnant woman with a prior obstetrical history of one abortion and two stillbirths was found to have had anti-M antibody titers 1:8 and accompanying elevated middle cerebral artery peak systolic velocity (MCA-PSV) of 1.9 MoM suggestive of severe fetal anemia at 17 weeks of gestation. Persistently elevated fetal MCA-PSV was noted despite intraperitoneal transfusion at 17, 19, and 22 weeks. Fetal blood sampling at 27 weeks confirmed severe fetal anemia (3 g/dL), which required additional intravascular and intraperitoneal blood transfusion. At 37 weeks, elective cesarean section was performed. Neonatal hemoglobin immediately after delivery was 10.1 g/dL. In addition to standard supportive care, the neonate required two additional transfusions and remained in the neonatal intensive care unit (NICU) for 23 days. Anti-M antibodies are a rare cause of severe alloimmunization. We present a case in order to improve management.

Indexed as

Anti-M IgGCase reportFetal hemolysisIntrauterine transfusionMCV-PSV

Identifiers

PMID38855719
PMCPMC11157218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.